Y.S.P. Southeast Asia Holding Berhad (KLSE:YSPSAH)
1.920
-0.030 (-1.54%)
At close: Nov 20, 2026
KLSE:YSPSAH Revenue
Y.S.P. Southeast Asia Holding Berhad had revenue of 93.57M MYR in the quarter ending September 30, 2026, with 1.36% growth. This brings the company's total for the last twelve months to 370.79M, up 0.99% year-over-year. In the year 2025, Y.S.P. Southeast Asia Holding Berhad had annual revenue of 365.12M, down -0.96%. That makes Y.S.P. Southeast Asia Holding Berhad the 23,527th largest company in the world by revenue and 378th in Malaysia.
Revenue (ttm)
370.79M
Revenue Growth
+0.99%
P/S Ratio
0.73
Revenue / Employee
272.44K
Employees
1,361
Market Cap
272.34M
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full KLSE:YSPSAH breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 365.12M | -3.54M | -0.96% |
| Dec 31, 2024 | 368.66M | 13.66M | 3.85% |
| Dec 31, 2023 | 355.00M | 20.75M | 6.21% |
| Dec 31, 2022 | 334.25M | 52.39M | 18.59% |
| Dec 31, 2021 | 281.86M | -15.20M | -5.12% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| DXN Holdings Bhd. | 1.92B |
| Duopharma Biotech Berhad | 916.98M |
| Kotra Industries Berhad | 233.17M |
| Rhone Ma Holdings Berhad | 228.88M |
| Sunzen Group Berhad | 93.59M |
| PeterLabs Holdings Berhad | 63.47M |
| Nova Wellness Group Berhad | 49.74M |
| Bioalpha Holdings Berhad | 10.93M |